The Genomics Platform Group at UMCCR strives to improve the scalability and reliability of sequencing workflows, enable better detection of changes in cancer genomes, and make tumor data accessible in real time.
The Group needed a scalable, commercially supported, cloud-based environment for running and sharing workflows for analyzing and reporting genomics data.
The team chose to migrate current workflows and systems to Illumina Connected Analytics.
Using Illumina Connected Analytics, the Genomics Platform Group has been able to digitally transform their sequencing workflows by optimizing and standardizing their analytic pipelines, streamlining the timeline from data output to curated report, and sharing workflows and processes across national and global collaborators all within a secure and compliant data environment.
The mission of the University of Melbourne Centre for Cancer Research (UMCCR) is to “drive innovation and implementation for clinical impact in cancer care.” Led by Sean Grimmond, the UMCCR is working to accelerate improved outcomes for cancer patients through the use of genomic information in understanding cancer development and targeting therapies. The UMCCR collaborates with Victorian Comprehensive Cancer Centre (VCCC) Alliance partners to enable personalized cancer care programs across institutions.
A key part of this endeavor is ensuring that results from next-generation sequencing (NGS) data processing, analysis, and interpretation are broadly available to researchers and clinicians. This is the goal of the Genomics Platform Group at UMCCR, to improve “the scalability and reliability of sequencing workflows, better detect changes in cancer genomes, and make tumor data accessible in real time.” To help achieve this objective, Dr. Oliver Hofmann, Associate Professor and Head of Bioinformatics, Clinical Pathology at UMCCR and the leader of the Genomics Platform Group, partnered with Illumina to gain early access to Illumina Connected Analytics.